Beverley A. Orser MD, FRCPC, PhD
Associate Professor of Anesthesia and Physiology, University of Toronto
Dr. Beverley A. Orser is Professor of Anesthesia and Physiology at the University of Toronto, a Canada Research Chair in Anesthesia and a practising anesthesiologist at Sunnybrook Health Sciences. She received a Medical Doctorate from Queen's University in 1981, a Fellowship from the Royal College of Physicians and Surgeons of Canada in 1987, and a PhD in medical science from the University of Toronto in 1995. She completed postgraduate clinical training programs at the Royal Columbian Hospital, McMaster University, Oxford University and the University of Toronto. Her research focuses on the molecular mechanism of anesthetics and analgesics. She holds a Canada Research Chair in Anesthesia and operating grants from the Canadian Institutes of Health Research. Her clinical studies focus on simple but effective ways to improve patient safety in the operating room. She co-founded the Institute for Safe Medication Practices Canada, the first Canadian reporting system for medication errors and the Patient Safety Committee of the Canadian Anesthesiologists' Society. She has also chaired the Canadian Standards Association Subcommittee on the Labeling and Packaging of Drugs and helped to develop a tool that can be used to assess drug hazards in the operating room. Her recent efforts have been directed to the implementation of safety checklists for patients undergoing surgery. Dr. Orser's work has been recognized through numerous awards, including a Canada Research Chair, the first Frontiers in Anesthesia Research Award from the International Anesthesia Research Society and a Research Recognition Award from the Canadian Anesthesiologists' Society. She has also received the Recognition Award from the Institute for Safe Medication Practices (United States), the Premier's Research Excellence Award (Ontario) and a Career Scientist Award from the Ontario Ministry of Health and Long-Term Care.
Carole R Chambers BSc(Pharm) MBA, FCSHP, FISOPP
Pharmacy Director - Cancer Services, Alberta Health Services
Carole R Chambers BSc(Pharm) MBA, FCSHP, FISOPP is the Pharmacy Director - Cancer Services, Alberta Health Services with over 50 peer reviewed publications.
Carole has received the Distinguished Service Award from the Canadian Association of Pharmacy in Oncology (2005), and an Achievement Award (2006) from the International Society of Oncology Pharmacy Practitioners (ISOPP) for longstanding commitment to oncology pharmacy practice through sustained excellence in providing oncology pharmacy services, leadership in innovative oncology pharmacy, related research and ongoing contributions to ISOPP. She served as President for ISOPP between 2008-2010. In 2011 she was awarded Fellowship status with the Canadian Society of Hospital Pharmacists, and in 2012 she was awarded Fellowship status with ISOPP.
Recently she has served on an international advisory panel for ISMP in the creation of a medication safety self assessment (MSSA) tool in oncology practice, and has given medication safety presentations in national symposia in Australia, Brazil and Canada.
Michael Cohen MS, RPh
President, ISMP US
Michael Cohen RPh, MS, ScD, is president of The Institute for Safe Medication Practices, a non-profit healthcare organization in the United States that specializes in understanding the causes of medication errors and providing error-reduction strategies to the healthcare community, policy makers, and the public. He is editor of the textbook, Medication Errors (2007 American Pharmaceutical Association) and serves as co-editor of the ISMP Medication Safety Alert! publications that reach over 2 million health professionals and consumers in the US, as well as regulatory authorities and others in over 30 foreign countries. Dr. Cohen is vice-chair of the Sentinel Event Advisory Group for the Joint Commission and served recently as a member of the National Quality Forum's Voluntary Consensus Standards Maintenance Committee (CSMC) on Safe Practices. He currently serves as a consultant to the FDA Drug Safety and Risk Management Committee. In 2005 he was recognized as a MacArthur Fellow by the John D. and Catherine T. MacArthur Foundation.
Peter A. Flattery B.A., M.B.A., C.I.P.
Chief Executive Officer of Healthcare Insurance Reciprocal of Canada (HIROC)
Peter Flattery is Chief Executive Officer of Healthcare Insurance Reciprocal of Canada (HIROC). He started with the founding organization, Hospital Insurance Reciprocal of Ontario (HIRO) in 1988, during its first year of operation, as head of the Underwriting & Client Services Department. In 1996 Peter was named CEO and has expanded the mandate of the organization in co-operation with the interests of its Subscribers. During his tenure, HIROC has become Canada's largest healthcare liability insurer and a leading provider of innovative risk management and patient safety products and services.
After graduating from the University of Toronto, Peter joined a large international commercial insurance company, where he spent eleven years specializing in the underwriting and marketing areas of casualty and property insurance. He is a graduate of the Executive MBA program at Queen's University and is a Chartered Insurance Professional of the Insurance Institute of Canada.
Peter is immediate past Chair of the Board of Hospital Insurance Forum, a U.S.-based association of medical malpractice insurers; Board Chair of Salus Global Corporation, an organization dedicated to improving patient safety; and, Board Chair of Canadian Association of Insurance Reciprocals, established to raise awareness of the value of insurance reciprocals and represent its members' interests to government regulators and other stakeholders.
Robert Byrick MD, FRCPC*
Department of Anesthesia, St. Michael's Hospital
Dr. Byrick is a practicing clinical anesthesiologist at St. Michael's Hospital where he has practiced since 1978. He completed his postgraduate training in Anesthesia at the University of Toronto and was Director of Critical Care and Chief of the Department of Anesthesia at St. Michael's from 1987-1993. He served as Chairman of the Department of Anesthesia from 1993-2003 and later as Vice-Dean of Clinical Affairs, University of Toronto. His research has focused on applied clinical physiology and pharmacology in the peri-operative setting. During his time as Vice Dean, he was involved in the development of the University of Toronto's, Centre for Patient Safety and was the Acting Director of the Centre at its inception.
He was appointed to the Council of the College of Physicians and Surgeons of Ontario in 2004, as the University of Toronto's representative. He served as President of the CPSO in 2012 and continues to serve on Council.
Ruth Wilson MD, CCFP
Department of Family Medicine, Queen's University
Dr. Ruth Wilson is the Associate Director of Health Policy at the College of Family Physicians of Canada and outgoing Chair of the Canadian Medical Forum, a roundtable of CEOs and presidents of Canada's major medical organizations. She is a practising family physician and educator. A professor of family medicine at Queen's University, she was Chair of the department for ten years. From 2001-2004, she served as Chair of the Ontario Family Health Network, a provincial government agency created to implement primary care reform in Ontario. This effort laid the groundwork for the widespread primary care models in Ontario including Family Health Teams.
Her practice as a family physician includes eleven years in remote communities in Canada, and twenty-two years in Kingston, Ontario, where she includes obstetrics in her practice. Her international experience includes helping establish family medicine in the immediate post-conflict situation in Bosnia-Herzegovina.
Wilson's research interests are in women's health, aboriginal health, and the lessons from these areas that affect the determinants of health. She is co-author of the Women's Health chapters of the Oxford Textbook of Primary Care, and editor of Implementing Primary Care Reform: Barriers and Facilitators. She is outgoing Chair of the National Drug Scheduling Advisory Committee.
She is the recipient of a Canada 125 Medal. In May 2002, Wilson received an honorary Doctor of Laws from Thompson Rivers University. In 2010 Wilson was named one of two 5 Star Doctors by WONCA, the World Organization of Family Doctors. Also in 2010 she was named one of Canada's Top 100 Most Powerful Women.
W. Morley Lemon PhD, FCA, CPA
Professor Emeritus, University of Waterloo
W. Morley Lemon PhD, (University of Texas at Austin); FCA (Ontario), CPA (Texas) is Professor Emeritus, University of Waterloo. He was the PricewaterhouseCoopers Professor of Auditing at his retirement in 2004. Morley a KPMG Audit Research Fellow from 1985 to 1986 and a Visiting Professor at the University of Texas at Austin (Fall 2003, Spring 2006, 2007, 2008, 2009) and the University of Auckland (Spring 2004, 2005).
Morley received the University of Waterloo Distinguished Teacher Award in 1998, the ICAO Award of Outstanding Merit in 2003, CAAA L.S. Rosen Outstanding Educator Award in 2004, and the American Accounting Association Auditing Section Distinguished Service Award in 2010.
Service to the profession includes the CICA Auditing Standards Board 1996-2000 and several CICA Task Forces. Morley also served on the Canada/US/UK Joint Working Group to Examine Audit Methodology (1999-2000) and was co-author of Developments in the Audit Methodologies of Large Accounting Firms published by the Auditing Practices Board, London in 2000.
Service to the academy includes membership on a number of CAAA committees and membership on the AAA Council and of a number of AAA committees. Morley has presented papers in Canada, the U.S., Australia and China. and has papers published in several journals and monographs.
Other service includes membership on the Boards of Transparency International Canada, The Salvation Army Toronto Grace Health Centre (including two years as Chair, and ISMP Canada.
Board of Directors:
Advisors to the Board (Non-Voting)
Cecil Schwartz, LLB